Call (289) 812-0046
Clinical Trial
For adults (≥18) with moderate to severe hidradenitis suppurativa (subcutaneous study drug)
RECRUITING
Phase 3 | Injection | 52 weeks
CLINICAL TRIAL
Trial ID: NCT06468228
Phase 3 | Subcutaneous | 52 weeks
Trial ID: NCT06958211
Phase 3 | Topical | 52 weeks
Trial ID: NCT07170917
Phase 2 | Subcutaneous | 60 weeks
Trial ID: NCT06799000
Phase 3 | Oral | 52 weeks